Free Trial

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Trading Down 0.9% - Should You Sell?

RHÖN-KLINIKUM Aktiengesellschaft logo with Medical background

Key Points

  • Shares of RHÖN-KLINIKUM Aktiengesellschaft fell by 0.9% to €11.60 ($13.81) amid a significant drop in trading volume, with only 424 shares exchanged compared to an average of 43,281.
  • The company has a market capitalization of $770.98 million and exhibits a P/E ratio of 17.18 and a PEG ratio of 26.77, indicating its valuation metrics.
  • RHÖN-KLINIKUM provides a range of healthcare services in Germany, including treatment for neurological conditions, rehabilitation, and various surgeries.
  • MarketBeat previews top five stocks to own in October.

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK - Get Free Report) shares dropped 0.9% during mid-day trading on Tuesday . The company traded as low as €11.60 ($13.65) and last traded at €11.60 ($13.65). Approximately 424 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 43,281 shares. The stock had previously closed at €11.70 ($13.76).

RHÖN-KLINIKUM Aktiengesellschaft Stock Up 0.9%

The stock has a fifty day moving average of €11.86 and a 200-day moving average of €12.88. The stock has a market capitalization of $770.98 million, a price-to-earnings ratio of 17.18, a P/E/G ratio of 26.77 and a beta of -0.13.

RHÖN-KLINIKUM Aktiengesellschaft Company Profile

(Get Free Report)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases.

See Also

Should You Invest $1,000 in RHÖN-KLINIKUM Aktiengesellschaft Right Now?

Before you consider RHÖN-KLINIKUM Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHÖN-KLINIKUM Aktiengesellschaft wasn't on the list.

While RHÖN-KLINIKUM Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.